BioTech/Drugs - Cleveland, OH, US
NEO Proteomics offers protein structure characterization services to industry and academic laboratories. NEO's team of world-class experts is lead by Dr. Mark Chance, NEO Proteomics, Chief Scientific Officer and Co-Founder. Dr. Chance has pioneered covalent labeling by mass spectrometry (CL-MS), also known as protein footprinting, as a fast, high-resolution approach to protein characterization. NEO Proteomics offers protein footprinting services along with other biophysical techniques to enable research organizations access to complete structure interrogation through cutting edge science and world-class expertise on a per-project basis.
Gmail
WordPress.org
Google Apps
Amazon AWS
SuperStats